XAIR News and Press, Beyond Air Inc. From 11/14/23

2023-11-14 14:22:16 ET Gainers: BioCardia ( BCDA ) +170% . reAlpha Tech Corp. ( AIRE ) +119% . Turnstone Biologics Corp ( TSBX ) +75% . Theseus Pharmaceuticals ( THRX ) +49% . American Coastal Insurance Corp ( ACIC ) +38% . M...

2023-11-14 10:04:00 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...

2023-11-13 19:07:02 ET Beyond Air, Inc. (XAIR) Q2 2024 Earnings Conference Call November 13, 2023, 04:30 PM ET Company Participants Edward Barger - Head of Investor Relations Steve Lisi - Chairman and Chief Executive Officer Duncan Fatkin - Chief Commercial Offic...

2023-11-13 16:16:26 ET More on Beyond Air Beyond Air enters into strategic collaboration with Getz Healthcare Beyond Air spikes after insider purchase Seeking Alpha’s Quant Rating on Beyond Air Historical earnings data for Beyond Air Financial ...

Provides fiscal year 2025 revenue guidance of $12 - $16 million US pilot trial of LungFit ® PRO to treat viral community acquired pneumonia (VCAP) underway with data expected mid-calendar 2024 Beyond Cancer presents positive first-in-human data for intratumoral administ...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

Beyond Air Inc. (XAIR) is expected to report $-0.47 for Q2 2024

2023-11-12 17:35:49 ET Major earnings expected after the bell on Monday include: Fisker ( FSR ) Star Bulk Carriers Corp. ( SBLK ) Gevo ( GEVO ) Danaos Corporation ( DAC ) Zomedica Corp. ( ZOM ) For further details see: Notable earnings aft...

First-in-human Phase 1 study demonstrates early clinical proof of concept Positive clinical biomarker data demonstrate evidence of immune system activation and the translation of the immunogenic response previously observed in preclinical studies Data represent the first success...

Beyond Air, Inc. (NASDAQ: XAIR) is one of today's top gainers. The company's shares are currently up 9.28% on the day to $2.42. Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing ...